On Monday, Ocugen Inc (NASDAQ: OCGN) opened lower -4.46% from the last session, before settling in for the closing price of $1.03. Price fluctuations for OCGN have ranged from $0.51 to $1.98 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 32.82% over the past five years. Company’s average yearly earnings per share was noted -10.00% at the time writing. With a float of $286.77 million, this company’s outstanding shares have now reached $292.03 million.
Let’s look at the performance matrix of the company that is accounted for 95 employees. In terms of profitability, gross margin is 100.0%, operating margin of -1261.43%, and the pretax margin is -1271.12%.
Ocugen Inc (OCGN) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Ocugen Inc is 1.80%, while institutional ownership is 26.40%. The most recent insider transaction that took place on Jun 11 ’25, was worth 171,029. Before that another transaction happened on Nov 26 ’24, when Company’s Director bought 10,000 for $0.91, making the entire transaction worth $9,095. This insider now owns 10,000 shares in total.
Ocugen Inc (OCGN) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -10.00% per share during the next fiscal year.
Ocugen Inc (NASDAQ: OCGN) Trading Performance Indicators
Check out the current performance indicators for Ocugen Inc (OCGN). In the past quarter, the stock posted a quick ratio of 2.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 63.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.19, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.24 in one year’s time.
Technical Analysis of Ocugen Inc (OCGN)
Ocugen Inc (NASDAQ: OCGN) saw its 5-day average volume 15.5 million, a positive change from its year-to-date volume of 4.84 million. As of the previous 9 days, the stock’s Stochastic %D was 19.06%.
During the past 100 days, Ocugen Inc’s (OCGN) raw stochastic average was set at 60.53%, which indicates a significant increase from 8.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.96% in the past 14 days, which was lower than the 84.72% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8631, while its 200-day Moving Average is $0.8356. Nevertheless, the first resistance level for the watch stands at $1.0547 in the near term. At $1.1253, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.1606. If the price goes on to break the first support level at $0.9488, it is likely to go to the next support level at $0.9135. Assuming the price breaks the second support level, the third support level stands at $0.8429.
Ocugen Inc (NASDAQ: OCGN) Key Stats
There are currently 292,031K shares outstanding in the company with a market cap of 287.39 million. Presently, the company’s annual sales total 4,060 K according to its annual income of -54,050 K. Last quarter, the company’s sales amounted to 1,480 K and its income totaled -15,350 K.
